KR101080001B1 - 졸피뎀 또는 그의 약제학적으로 허용되는 염을 포함하는 구강 속붕해정 - Google Patents
졸피뎀 또는 그의 약제학적으로 허용되는 염을 포함하는 구강 속붕해정 Download PDFInfo
- Publication number
- KR101080001B1 KR101080001B1 KR1020090004257A KR20090004257A KR101080001B1 KR 101080001 B1 KR101080001 B1 KR 101080001B1 KR 1020090004257 A KR1020090004257 A KR 1020090004257A KR 20090004257 A KR20090004257 A KR 20090004257A KR 101080001 B1 KR101080001 B1 KR 101080001B1
- Authority
- KR
- South Korea
- Prior art keywords
- mannitol
- delete delete
- zolpidem
- oral
- disintegrating tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
조성 | 비율(중량%) | |||
실시예1 | 실시예2 | 실시예3 | 실시예4 | |
졸피뎀타르타르산염 | 4.0 | 4.0 | 4.0 | 4.0 |
디-만니톨 (전혼합) | 33.4 | 33.4 | 33.4 | 33.4 |
디-만니톨 (후혼합) | 33.4 | 33.4 | 33.4 | 33.4 |
크로스포비돈 (전혼합) | 8.0 | 8.0 | 8.0 | 8.0 |
크로스포비돈 (후혼합) | 8.0 | 8.0 | 8.0 | 8.0 |
경질무수규산 | 2.0 | 2.0 | 2.0 | 2.0 |
폴리비닐피롤리돈 | 0.8 | 0.8 | 0.8 | 0.8 |
탄산수소나트륨 | 4.0 | - | - | - |
탄산나트륨 | - | 4.0 | - | - |
탄산수소칼륨 | - | - | 4.0 | - |
탄산칼륨 | - | - | - | 4.0 |
오렌지미크론 | 2.0 | 2.0 | 2.0 | 2.0 |
아스파탐 | 2.4 | 2.4 | 2.4 | 2.4 |
스테아르산마그네슘 | 2.0 | 2.0 | 2.0 | 2.0 |
조성 | 비율(중량%) | ||
비교예 1 | 비교예2 | 비교예3 | |
졸피뎀타르타르산염 | 4.4 | 4.4 | 4.0 |
디-만니톨 | 67.4 | 71.7 | 67.6 |
경질무수규산 | - | - | 2.0 |
탄산수소나트륨 | 8.7 | 4.4 | 4.0 |
크로스포비돈 | 13.0 | 13.0 | 16.0 |
오렌지미크론 | 2.2 | 2.2 | 2.0 |
아스파탐 | 2.6 | 2.6 | 2.4 |
스테아르산마그네슘 | 1.7 | 1.7 | 2.0 |
조성 | 비율(중량%) | ||||
비교예4 | 비교예5 | 비교예6 | 비교예7 | 비교예8 | |
졸피뎀타르타르산염 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 |
디-만니톨 | 76.1 | 67.4 | 67.4 | 67.4 | 67.4 |
메타규산알루민산마그네슘 | - | 8.7 | - | - | - |
산화마그네슘 | - | - | 8.7 | - | - |
건조수산화알루미늄겔 | - | - | - | 8.7 | - |
탄산마그네슘 | - | - | - | - | 8.7 |
크로스포비돈 | 13.0 | 13.0 | 13.0 | 13.0 | 13.0 |
오렌지미크론 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 |
아스파탐 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 |
스테아르산마그네슘 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 |
Claims (20)
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 졸피뎀 또는 이의 약학적으로 허용 가능한 염을 폴리비닐피롤리돈(포비돈)을 포함하는 결합용액을 사용하여 제립함으로써 습식과립물을 제조하는 단계;상기 습식과립물에 탄산수소나트륨, 탄산수소칼륨, 탄산나트륨 및 탄산칼륨으로 이루어진 그룹으로부터 선택되며, 평균입자크기가 10 내지 250㎛인 하나의 알칼리화제를 첨가하여 혼합물을 제조하는 단계; 및상기 혼합물을 타정하여 정제를 제조하는 단계를 포함하는 졸피뎀 구강 속붕해정의 제조방법.
- 제16항에 있어서, 상기 알칼리화제는 탄산수소나트륨인 것인 졸피뎀 구강 속붕해정의 제조방법.
- 제16항에 있어서, 상기 습식과립물을 제조하는 단계는,크로스포비돈 및 만니톨(D-만니톨, L-만니톨, DㆍL-만니톨)을 첨가하는 단계를 더 포함하는 것인 졸피뎀 구강 속붕해정의 제조방법.
- 제16항에 있어서, 상기 혼합물을 제조하는 단계는,크로스포비돈 및 만니톨(D-만니톨, L-만니톨, DㆍL-만니톨)을 첨가하는 단계를 더 포함하는 것인 졸피뎀 구강 속붕해정의 제조방법.
- 폴리비닐피롤리돈(포비돈)을 포함하는 결합용액으로 졸피뎀 또는 이의 약학적으로 허용 가능한 염, 크로스포비돈 및 만니톨(D-만니톨, L-만니톨, DㆍL-만니톨)을 제립하여 습식과립물을 제조하는 단계;상기 습식과립물에 크로스포비돈, 만니톨(D-만니톨, L-만니톨, DㆍL-만니톨), 및 탄산수소나트륨, 탄산수소칼륨, 탄산나트륨 및 탄산칼륨으로 이루어진 그룹으로부터 선택되며, 평균입자크기가 10 내지 250㎛인 하나의 알칼리화제를 첨가하여 혼합물을 제조하는 단계; 및상기 혼합물을 타정하여 정제를 제조하는 단계를 포함하는 졸피뎀 구강 속붕해정의 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090004257A KR101080001B1 (ko) | 2009-01-19 | 2009-01-19 | 졸피뎀 또는 그의 약제학적으로 허용되는 염을 포함하는 구강 속붕해정 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090004257A KR101080001B1 (ko) | 2009-01-19 | 2009-01-19 | 졸피뎀 또는 그의 약제학적으로 허용되는 염을 포함하는 구강 속붕해정 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20100084882A KR20100084882A (ko) | 2010-07-28 |
KR101080001B1 true KR101080001B1 (ko) | 2011-11-04 |
Family
ID=42644049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090004257A KR101080001B1 (ko) | 2009-01-19 | 2009-01-19 | 졸피뎀 또는 그의 약제학적으로 허용되는 염을 포함하는 구강 속붕해정 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101080001B1 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130025851A (ko) * | 2011-09-02 | 2013-03-12 | 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 | 메게스트롤 속붕해정 및 이의 제조 방법 |
KR20130076015A (ko) | 2011-12-28 | 2013-07-08 | 주식회사 삼양바이오팜 | 높은 경도를 갖는 속붕정 및 이의 제조 방법 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050226925A1 (en) * | 2004-02-17 | 2005-10-13 | Transoral Pharmaceuticals, Inc. | Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
-
2009
- 2009-01-19 KR KR1020090004257A patent/KR101080001B1/ko active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050226925A1 (en) * | 2004-02-17 | 2005-10-13 | Transoral Pharmaceuticals, Inc. | Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20100084882A (ko) | 2010-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8153161B2 (en) | Medicament-containing particle and a solid preparation containing the particle | |
JP4989733B2 (ja) | 口腔内崩壊錠 | |
US8048449B2 (en) | Mouth dissolving pharmaceutical composition and process for preparing the same | |
KR101528954B1 (ko) | 이미다페나신 함유 구강 내 속붕괴성 정제 | |
JP2001058944A (ja) | 速崩壊性固形製剤 | |
CA2476170A1 (en) | Fast disintegrating tablets | |
JP2008531681A (ja) | 炭酸マグネシウムヘビーを含む速崩壊型製剤 | |
CA2249952A1 (en) | Rapidly soluble solid in the oral cavity and process for producing the same | |
JPH0948726A (ja) | 口腔内速崩壊性製剤およびその製法 | |
KR100759720B1 (ko) | 구강내 속붕괴정 | |
WO2010045788A1 (zh) | 盐酸多奈哌齐口腔崩解片及其制备方法 | |
EP1773292B1 (en) | Rapidly disintegrating orodispersible composition containing nonfilamentous coprocessed polyols particles and silicified microcrystalline cellulose | |
KR101109633B1 (ko) | 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물 | |
JP2004175796A (ja) | 排尿障害治療用口腔内崩壊製剤 | |
EP1768673B1 (en) | Orally disintegrating pharmaceutical composition comprising risperidone | |
JP2003034655A (ja) | 速崩壊性固形製剤 | |
JP2002255796A (ja) | 口腔内速崩壊型錠剤及びその製造方法 | |
KR20100031282A (ko) | 메만틴염산염 구강 속붕해정 | |
WO2006087629A2 (en) | Rapidly disintegrating composition of olanzapine | |
US20100055179A1 (en) | Composition of and Method for Preparing Orally Disintegrating Tablets Containing a High Dose of Pharmaceutically Active Ingredients | |
KR101080001B1 (ko) | 졸피뎀 또는 그의 약제학적으로 허용되는 염을 포함하는 구강 속붕해정 | |
KR101111534B1 (ko) | 구강 속붕해성 조성물 및 이의 제조방법 | |
EP3576718B1 (en) | A lozenge | |
KR100855189B1 (ko) | 구강 속붕해성 정제 | |
KR100503949B1 (ko) | 염산 온단세트론의 쓴맛을 효과적으로 은폐한 경구용 구강속붕해정 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20140905 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150911 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20160909 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20170911 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20180910 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20190918 Year of fee payment: 9 |